The estimated Net Worth of Management Ltd Abg Srne Ltd... is at least $15 mil dollars as of 13 April 2017. Management Ltd owns over 2,500,000 units of Sorrento Therapeutics Inc stock worth over $15,000 and over the last 8 years Management sold SRNE stock worth over $0.
Management has made over 1 trades of the Sorrento Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Management bought 2,500,000 units of SRNE stock worth $5,000,000 on 13 April 2017.
The largest trade Management's ever made was buying 2,500,000 units of Sorrento Therapeutics Inc stock on 13 April 2017 worth over $5,000,000. On average, Management trades about 2,500,000 units every 0 days since 2017. As of 13 April 2017 Management still owns at least 1,500,000 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Management Ltd stock trades at the bottom of the page.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee y Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: